Said it was expensive, but covered by my insurance. She couldn't give a rats #$%$ if VRX stock has been under a little selling pressure.
My conclusion is that every doc feels the same way. Up we go boys!!!
Tax loss selling and plain vanilla fund managers' reckless selling for window dressing purposes has passed its peak. Deep value investors willing to step in here will do very well.
Announce date for Fiscal 2015 earnings
File form for insider buying
Sign international license agreement
Float a China Chem acquisition rumor
Likely acquisition candidate at this extremely depressed valuation level of F 3.8X P/S.
Oh cool, my long-term equity investment in VRX is still bouncing hard off the bottom. Now back to my early Christmas shopping at Bergdorf.
Only in New York my friends, only in New York
2016 revenue outlook of $618 - 635M is very respectable. Everything looks on track except the stock price.
And now we have an upgrade report this morning from Canaccord who thinks that CGNX will resume large orders in 2016.